Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stanton

Showing results (331-340 of 382) with videos related to

Pageof 39
Sort By:
Stroke|February 28, 2023
Using Epidemiological Data to Inform Clinical Trial Feasibility Assessments: A Case StudyRobert J Stanton, David J Robinson, Yasmin N Aziz, et al.
Pharmaceutics|September 28, 2024
Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral StrategiesDebora Obergfäll, Markus Wild, Mona Sommerer, et al.
Wellcome Open Research|December 9, 2022
Quantitative proteomic analysis of SARS-CoV-2 infection of primary human airway ciliated cells and lung epithelial cells demonstrates the effectiveness of SARS-CoV-2 innate immune evasionThomas W M Crozier, Edward J D Greenwood, James C Williamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2020
Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant CellsMartin J Scurr, Alex Greenshields-Watson, Emma Campbell, et al.
Genome Announcements|August 13, 2016
Genome Sequences of Gordonia Phages Hotorobo, Woes, and MontyWelkin H Pope, Jameson P Davis, Sirinya O'Shea, et al.
Molecular Therapy. Methods & Clinical Development|August 29, 2024
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applicationsCarly M Bliss, Sarah L Hulin-Curtis, Marta Williams, et al.
Journal of the American Heart Association|June 21, 2024
Clinical Trial Exclusion Criteria Affect Trial Inclusivity by Race and SexRobert J Stanton, Yasmin N Aziz, Heidi Sucharew, et al.
Plos Pathogens|May 3, 2014
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradationCeri A Fielding, Rebecca Aicheler, Richard J Stanton, et al.
Nature Communications|September 8, 2022
IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responsesM Clement, J L Forbester, M Marsden, et al.
Cell Host & Microbe|August 15, 2014
HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cellsRichard J Stanton, Virginie Prod'homme, Marco A Purbhoo, et al.
Pageof 39

Showing results (331-340 of 382) with videos related to

Sort By:
Pageof 39
Stroke|February 28, 2023
Using Epidemiological Data to Inform Clinical Trial Feasibility Assessments: A Case StudyRobert J Stanton, David J Robinson, Yasmin N Aziz, et al.
Pharmaceutics|September 28, 2024
Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral StrategiesDebora Obergfäll, Markus Wild, Mona Sommerer, et al.
Wellcome Open Research|December 9, 2022
Quantitative proteomic analysis of SARS-CoV-2 infection of primary human airway ciliated cells and lung epithelial cells demonstrates the effectiveness of SARS-CoV-2 innate immune evasionThomas W M Crozier, Edward J D Greenwood, James C Williamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2020
Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant CellsMartin J Scurr, Alex Greenshields-Watson, Emma Campbell, et al.
Genome Announcements|August 13, 2016
Genome Sequences of Gordonia Phages Hotorobo, Woes, and MontyWelkin H Pope, Jameson P Davis, Sirinya O'Shea, et al.
Molecular Therapy. Methods & Clinical Development|August 29, 2024
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applicationsCarly M Bliss, Sarah L Hulin-Curtis, Marta Williams, et al.
Journal of the American Heart Association|June 21, 2024
Clinical Trial Exclusion Criteria Affect Trial Inclusivity by Race and SexRobert J Stanton, Yasmin N Aziz, Heidi Sucharew, et al.
Plos Pathogens|May 3, 2014
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradationCeri A Fielding, Rebecca Aicheler, Richard J Stanton, et al.
Nature Communications|September 8, 2022
IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responsesM Clement, J L Forbester, M Marsden, et al.
Cell Host & Microbe|August 15, 2014
HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cellsRichard J Stanton, Virginie Prod'homme, Marco A Purbhoo, et al.
Pageof 39